Skip to main content

Navigation group

Type at least 3 characters
214 articles

Articles

Brief Research Report

Published on 04 Mar 2022

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

in Diabetes Cardiovascular Complications

  • Asger Wretlind
  • Emilie Hein Zobel
  • Andressa de Zawadzki
  • Rasmus Sejersten Ripa
  • Viktor Rotbain Curovic
  • Bernt Johan von Scholten
  • Ismo Matias Mattila
  • Tine Willum Hansen
  • Andreas Kjær
  • Henrik Vestergaard
Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2022.856485
  • 2,835 views
  • 2 citations